Jefferies analyst Glen Santangelo raised the firm’s price target on Envista (NVST) to $22 from $20 and keeps a Hold rating on the shares. Expectations have recently been reset to “a more appropriate level” and shares are now trading closer to the historical average, notes the analyst, who remains “cautiously optimistic” that dental trends will improve in FY25.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.